Class II
Ongoing
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Why: Failed Dissolution Specifications: below specification
- Company
- Ajanta Pharma USA Inc
Bridgewater, NJ, United States - Reported
- Oct 7, 2026
- Recall started
- Sep 17, 2026
- Where sold
- Nationwide in the US.
- Amount
- Full product description
- Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
- Lots / codes affected
- Lot: DJ25134, Exp 11/30/2028
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.